Medical Properties Trust - Third Quarter 2026 Earnings Call - MEDICAL PROPERTIES TRUST INC

Financial Performance:

• Reported normalized FFO of $0.11 per share for Q3 2026, aligning with expectations, excluding September rent non-payment from HSA.
• Recognized a $70 million gain from a $123 million net discount on $2.4 billion secured debt refinancing completed in August.
• Recorded $158 million in aggregate gains from asset sales during the quarter; total cash rental revenue collected to date exceeds $750 million, annualizing above the $1 billion target.
• Incurred approximately $24 million in impairment charges, primarily due to the August earthquake impacting Colombian investments.
• GAAP expenses declined year-over-year, driven by reduced stock compensation from fair value adjustments on cash-settled awards.
• Asset sales since 2022 generated over $6.8 billion from properties originally costing $5.6 billion, representing a 23% increase over original undepreciated book values.
• Unencumbered assets to unsecured debt ratio stands at >180% as of September 30, with projected headroom up to 225% following Step Two debt refinancing.

Guidance and Future Outlook:

• Expects portfolio cash rent to remain above $1 billion annually despite 2027 asset sales, targeting long-term financial objectives.
• No specific date projected for the resumption of rent collections from HSA; current focus is on operational stabilization.
• Debt maturity profile expected to be reset with no maturities until June 2028 (approx. $600M sterling bonds), contingent on completing Step Two refinancing.
• Step Two debt restructuring includes extending the multi-year bank revolver, repaying a $200M term loan, and refinancing remaining $665M in 2027 notes.
• Dividend policy remains under review; management indicated options for capital allocation exist but has not committed to specific timing for dividend restoration or increases.

Business Segments and Product Lines:

• HSA (Post-Acute): Engaged Ovation Healthcare to manage operations and revenue cycle management (RCM); surgeries up 33% since September and cash collections up 24%; new HMO and residency agreements expected to boost CMS reimbursement.
• UK Behavioral Health: Priory lease restructured with an 18% rent reduction and a 10-year extension option (lease extendable to 2055); rent includes a variable component to recover foregone amounts upon revenue recovery.
• Post-Acute Care: Remains a portfolio differentiator with strong momentum; Earnest Health maintains 2.5x coverage, NOR achieves 2.4x coverage with full payments starting December.
• International: IMED (Spain) saw >11% volume growth driven by 40% surge in Valencia; Swiss Medical Network reported 2x coverage; Median delivered solid performance via orthopedic and addiction treatment volumes.
• Asset Development: NOR capital expenditure focuses on a new Emergency Department (ED) and seismic work; HSA development primarily addresses infrastructure upgrades (elevators, boilers, parking garage).

Market and Competitive Landscape:

• UK NHS budget constraints continue to limit funding for behavioral health demand, necessitating the Priory rent restructuring.
• Portfolio diversified across 50+ global operators, providing resilience against regional economic fluctuations.
• Asset sales transacted at attractive sub-7% cap rates in the U.S., indicating strong valuation demand for hospital real estate.
• Global demand for healthcare services remains robust, supporting the diverse operator model.

Risks and Challenges:

• HSA Revenue Cycle: Core challenge remains RCM and billing/collection efficiency despite operational volume growth; rent collection remains paused.
• Geopolitical/Environmental: Significant exposure to Colombian earthquake impacts requiring government engagement; potential for further volatility in Latin American markets.
• Interest Rate/Covenants: Dependence on successful completion of Step Two debt refinancing to eliminate secured leverage covenants and extend maturity profiles.
• Regulatory/Policy: UK NHS budgetary limits and U.S. payer mix changes (e.g., HMO agreements) directly impact revenue cycles.

Management Commentary and Tone:

• Tone is confident and solution-oriented, emphasizing the strength of the diversified portfolio and the efficacy of recent balance sheet restructuring.
• Management expressed strong confidence in Ovation's ability to resolve HSA's billing issues and Priory's operational potential post-lease restructuring.
• Emphasized "optionality" and "flexibility" regarding capital allocation, citing significant headroom and collateral capacity.
• Leadership highlighted that HSA operational volumes are actually improving, isolating the issue strictly to financial administration.

Analyst Questions and Answers:

• HSA Rent Resumption: Management declined to provide a specific timeline for rent resumption, citing ongoing review by Ovation, but noted operational metrics (surgeries, cash collections) are trending positively.
• HSA "Plan B": Management indicated a change in operators is only a consideration if operations decline; currently, confidence remains in the current operator with Ovation managing.
• Priority Restructuring Terms: Confirmed rent reduction is permanent at the base level, but variable rent mechanisms allow for rent recovery as revenue rebounds; lease extension to 2055 provides significant credit perimeter improvement for the parent.
• Capital Deployment: No specific asset sales currently pending; proceeds from recent sales and Step Two refinancing will address 2027 maturities, with excess cash available for longer-term debt management.
• Working Capital: Loan to HSA stands at $150 million; NOR is currently paying 50% of contractual rent, moving to 100% in December.

Other Key Points:

• HSA hospitals continue to operate under the HSA name despite the new management entity (Ardonis) entering the lease structure.
• The "two-step" debt reduction process is underway; Step One (secured notes issuance and extinguishment) is complete, with Step Two (revolver extension and 2027 notes refinancing) targeted for completion in coming weeks.
• Management reiterated the value of the "post-acute" differentiator and the stability of the general acute portfolio amidst behavioral health headwinds.